Global Liposome Drug Delivery Market Analysis and Forecast 2024-2030

Global Liposome Drug Delivery Market Analysis and Forecast 2024-2030


Summary

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

According to APO Research, The global Liposome Drug Delivery market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Liposome Drug Delivery, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Liposome Drug Delivery, also provides the sales of main regions and countries. Of the upcoming market potential for Liposome Drug Delivery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liposome Drug Delivery sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Liposome Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Liposome Drug Delivery sales, projected growth trends, production technology, application and end-user industry.

Liposome Drug Delivery segment by Company

Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Liposome Drug Delivery segment by Type

Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Liposome Drug Delivery segment by Application

Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Liposome Drug Delivery segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Liposome Drug Delivery in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Drug Delivery sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Liposome Drug Delivery Market by Type
1.2.1 Global Liposome Drug Delivery Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposome Drug Delivery Market by Application
1.3.1 Global Liposome Drug Delivery Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Liposome Drug Delivery Market Dynamics
2.1 Liposome Drug Delivery Industry Trends
2.2 Liposome Drug Delivery Industry Drivers
2.3 Liposome Drug Delivery Industry Opportunities and Challenges
2.4 Liposome Drug Delivery Industry Restraints
3 Global Market Growth Prospects
3.1 Global Liposome Drug Delivery Revenue Estimates and Forecasts (2019-2030)
3.2 Global Liposome Drug Delivery Revenue by Region
3.2.1 Global Liposome Drug Delivery Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Liposome Drug Delivery Revenue by Region (2019-2024)
3.2.3 Global Liposome Drug Delivery Revenue by Region (2025-2030)
3.2.4 Global Liposome Drug Delivery Revenue Market Share by Region (2019-2030)
3.3 Global Liposome Drug Delivery Sales Estimates and Forecasts 2019-2030
3.4 Global Liposome Drug Delivery Sales by Region
3.4.1 Global Liposome Drug Delivery Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Liposome Drug Delivery Sales by Region (2019-2024)
3.4.3 Global Liposome Drug Delivery Sales by Region (2025-2030)
3.4.4 Global Liposome Drug Delivery Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Liposome Drug Delivery Revenue by Manufacturers
4.1.1 Global Liposome Drug Delivery Revenue by Manufacturers (2019-2024)
4.1.2 Global Liposome Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Liposome Drug Delivery Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Liposome Drug Delivery Sales by Manufacturers
4.2.1 Global Liposome Drug Delivery Sales by Manufacturers (2019-2024)
4.2.2 Global Liposome Drug Delivery Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Liposome Drug Delivery Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Liposome Drug Delivery Sales Price by Manufacturers (2019-2024)
4.4 Global Liposome Drug Delivery Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Liposome Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Liposome Drug Delivery Manufacturers, Product Type & Application
4.7 Global Liposome Drug Delivery Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Liposome Drug Delivery Market CR5 and HHI
4.8.2 2023 Liposome Drug Delivery Tier 1, Tier 2, and Tier 3
5 Liposome Drug Delivery Market by Type
5.1 Global Liposome Drug Delivery Revenue by Type
5.1.1 Global Liposome Drug Delivery Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Liposome Drug Delivery Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
5.2 Global Liposome Drug Delivery Sales by Type
5.2.1 Global Liposome Drug Delivery Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Liposome Drug Delivery Sales by Type (2019-2030) & (K Vial)
5.2.3 Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
5.3 Global Liposome Drug Delivery Price by Type
6 Liposome Drug Delivery Market by Application
6.1 Global Liposome Drug Delivery Revenue by Application
6.1.1 Global Liposome Drug Delivery Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Liposome Drug Delivery Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
6.2 Global Liposome Drug Delivery Sales by Application
6.2.1 Global Liposome Drug Delivery Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Liposome Drug Delivery Sales by Application (2019-2030) & (K Vial)
6.2.3 Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
6.3 Global Liposome Drug Delivery Price by Application
7 Company Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Comapny Information
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
7.1.5 Gilead Sciences Recent Developments
7.2 Pacira
7.2.1 Pacira Comapny Information
7.2.2 Pacira Business Overview
7.2.3 Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Pacira Liposome Drug Delivery Product Portfolio
7.2.5 Pacira Recent Developments
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Comapny Information
7.3.2 Sun Pharmaceutical Business Overview
7.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
7.3.5 Sun Pharmaceutical Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Comapny Information
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
7.4.5 Johnson & Johnson Recent Developments
7.5 Luye Pharma
7.5.1 Luye Pharma Comapny Information
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
7.5.5 Luye Pharma Recent Developments
7.6 Sigma-Tau
7.6.1 Sigma-Tau Comapny Information
7.6.2 Sigma-Tau Business Overview
7.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
7.6.5 Sigma-Tau Recent Developments
7.7 Ipsen (Onivyde)
7.7.1 Ipsen (Onivyde) Comapny Information
7.7.2 Ipsen (Onivyde) Business Overview
7.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
7.7.5 Ipsen (Onivyde) Recent Developments
7.8 CSPC
7.8.1 CSPC Comapny Information
7.8.2 CSPC Business Overview
7.8.3 CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 CSPC Liposome Drug Delivery Product Portfolio
7.8.5 CSPC Recent Developments
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Comapny Information
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
7.9.5 Teva Pharmaceutical Recent Developments
7.10 Novartis
7.10.1 Novartis Comapny Information
7.10.2 Novartis Business Overview
7.10.3 Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Novartis Liposome Drug Delivery Product Portfolio
7.10.5 Novartis Recent Developments
7.11 Fudan-Zhangjiang
7.11.1 Fudan-Zhangjiang Comapny Information
7.11.2 Fudan-Zhangjiang Business Overview
7.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
7.11.5 Fudan-Zhangjiang Recent Developments
8 North America
8.1 North America Liposome Drug Delivery Market Size by Type
8.1.1 North America Liposome Drug Delivery Revenue by Type (2019-2030)
8.1.2 North America Liposome Drug Delivery Sales by Type (2019-2030)
8.1.3 North America Liposome Drug Delivery Price by Type (2019-2030)
8.2 North America Liposome Drug Delivery Market Size by Application
8.2.1 North America Liposome Drug Delivery Revenue by Application (2019-2030)
8.2.2 North America Liposome Drug Delivery Sales by Application (2019-2030)
8.2.3 North America Liposome Drug Delivery Price by Application (2019-2030)
8.3 North America Liposome Drug Delivery Market Size by Country
8.3.1 North America Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Liposome Drug Delivery Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Liposome Drug Delivery Market Size by Type
9.1.1 Europe Liposome Drug Delivery Revenue by Type (2019-2030)
9.1.2 Europe Liposome Drug Delivery Sales by Type (2019-2030)
9.1.3 Europe Liposome Drug Delivery Price by Type (2019-2030)
9.2 Europe Liposome Drug Delivery Market Size by Application
9.2.1 Europe Liposome Drug Delivery Revenue by Application (2019-2030)
9.2.2 Europe Liposome Drug Delivery Sales by Application (2019-2030)
9.2.3 Europe Liposome Drug Delivery Price by Application (2019-2030)
9.3 Europe Liposome Drug Delivery Market Size by Country
9.3.1 Europe Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Liposome Drug Delivery Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Liposome Drug Delivery Market Size by Type
10.1.1 China Liposome Drug Delivery Revenue by Type (2019-2030)
10.1.2 China Liposome Drug Delivery Sales by Type (2019-2030)
10.1.3 China Liposome Drug Delivery Price by Type (2019-2030)
10.2 China Liposome Drug Delivery Market Size by Application
10.2.1 China Liposome Drug Delivery Revenue by Application (2019-2030)
10.2.2 China Liposome Drug Delivery Sales by Application (2019-2030)
10.2.3 China Liposome Drug Delivery Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Liposome Drug Delivery Market Size by Type
11.1.1 Asia Liposome Drug Delivery Revenue by Type (2019-2030)
11.1.2 Asia Liposome Drug Delivery Sales by Type (2019-2030)
11.1.3 Asia Liposome Drug Delivery Price by Type (2019-2030)
11.2 Asia Liposome Drug Delivery Market Size by Application
11.2.1 Asia Liposome Drug Delivery Revenue by Application (2019-2030)
11.2.2 Asia Liposome Drug Delivery Sales by Application (2019-2030)
11.2.3 Asia Liposome Drug Delivery Price by Application (2019-2030)
11.3 Asia Liposome Drug Delivery Market Size by Country
11.3.1 Asia Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Liposome Drug Delivery Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Liposome Drug Delivery Market Size by Type
12.1.1 MEALA Liposome Drug Delivery Revenue by Type (2019-2030)
12.1.2 MEALA Liposome Drug Delivery Sales by Type (2019-2030)
12.1.3 MEALA Liposome Drug Delivery Price by Type (2019-2030)
12.2 MEALA Liposome Drug Delivery Market Size by Application
12.2.1 MEALA Liposome Drug Delivery Revenue by Application (2019-2030)
12.2.2 MEALA Liposome Drug Delivery Sales by Application (2019-2030)
12.2.3 MEALA Liposome Drug Delivery Price by Application (2019-2030)
12.3 MEALA Liposome Drug Delivery Market Size by Country
12.3.1 MEALA Liposome Drug Delivery Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Liposome Drug Delivery Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Liposome Drug Delivery Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Liposome Drug Delivery Value Chain Analysis
13.1.1 Liposome Drug Delivery Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Liposome Drug Delivery Production Mode & Process
13.2 Liposome Drug Delivery Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Liposome Drug Delivery Distributors
13.2.3 Liposome Drug Delivery Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings